Showing 3201-3210 of 5773 results for "".
- Alkeus’ Gildeuretinol Studied to Halt Progression of Early-Stage Stargardt Diseasehttps://modernod.com/news/alkeus-gildeuretinol-studied-to-halt-progression-of-early-stage-stargardt-disease/2482055/Alkeus Pharmaceuticals announced positive interim data showing gildeuretinol halted Stargardt disease progression for up to 6 years in the ongoing TEASE-3 clinical trial. The first three teenage patients with early-stage Stargardt disease enrolled in the trial and treated with oral gild
- Iridex 532 and Iridex 577 Lasers Launched in United Stateshttps://modernod.com/news/iridex-532-and-iridex-577-lasers-launched-in-united-states/2482054/Iridex announced the United States launch of its next-generation platform Iridex 532 and Iridex 577 lasers. According to the company, both lasers harness multiple treatment modes including continuous-wave and the company’s MicroPulse technology and an intuitive touchscreen interfa
- Harrow Launches Dry Eye Drug Vevye in the United Stateshttps://modernod.com/news/harrow-introduces-vevye-in-united-states-for-treatment-of-signs-and-symptoms-of-dry-eye-disease/2482053/Harrow announced that Vevye (cyclosporine ophthalmic solution) 0.1% is now available in the United States. It is indicated for treating the signs and symptoms of dry eye disease (DED). Vevye is the company’s nonpreserved, twice-daily dosed prescription drug based on a water free s
- Zeiss’ Visumax 800 With Smile Pro Software Approved by FDAhttps://modernod.com/news/zeiss-visumax-800-with-smile-pro-software-approved-by-fda/2482056/Zeiss Medical Technology announced that the FDA has approved the Visumax 800 With Smile Pro software for surgically treating nearsightedness, with or without astigmatism. This latest generation of femtosecond lasers from Zeiss enters the United States market as the technology is being broadly ado
- Nidek Launches Mirante Scanning Laser Ophthalmoscope in the United Stateshttps://modernod.com/news/nidek-launches-mirante-scanning-laser-ophthalmoscope-in-the-united-states/2482052/Nidek announced the commercial launch of the Mirante Scanning Laser Ophthalmoscope (SLO) in the United States. The Mirante is a multimodal fundus-imaging platform that combines high-definition SLO and optical coherence tomography (OCT) with ultra-wide field imaging. The multimodal platf
- EyePoint Begins Phase 2 VERONA Clinical Trial of EYP-1901 to Treat Diabetic Macular Edemahttps://modernod.com/news/eyepoint-begins-phase-2-verona-clinical-trial-of-eyp-1901-to-treat-diabetic-macular-edema/2482049/EyePoint Pharmaceuticals, a company focused on therapeutics for retinal diseases, announced that the first patient has been dosed in the VERONA clinical trial of the company’s EYP-1901 for diabetic macular edema (DME). EYP-1901 is an investigational sustained delivery therapy containing vor
- EssilorLuxottica Showcases Nuance Audio Smart Eyewear With Hearing-Aid Solutionhttps://modernod.com/news/essilorluxottica-showcases-nuance-audio-smart-eyewear-with-hearing-aid-solution/2482051/EssilorLuxottica announced it will showcase its consumer technology at CES 2024, the Consumer Electronics Show held by the Consumer Technology Association on January 9-12 in Las Vegas, Nevada. The company is a France-based designer, manufacturer, and global distributor of eyecare and eyewear prod
- Gentex Acquires eSighthttps://modernod.com/news/gentex-acquires-esight/2482048/Gentex announced the asset acquisition of eSight, a provider of vision enhancement technologies, to develop and manufacture next-generation mobile electronic eyewear that is designed to help people living with visual impairments. The company will feature eSight’s technology at CES 2024, the
- Bausch + Lomb Receives FDA Approval for Teneo Excimer Laser Platform for Myopia and Myopic Astigmatism LASIKhttps://modernod.com/news/bausch-lomb-receives-fda-approval-for-teneo-excimer-laser-platform-for-myopia-and-myopic-astigmatism-lasik/2482047/Bausch + Lomb announced that the FDA has approved the Teneo Excimer Laser Platform for laser-assisted in situ keratomileusis (LASIK) vision correction surgery for myopia and myopic astigmatism. “Teneo has been well received and is widely adopted in more than 50 countries arou
- Alimera Completes Recruitment for the Synchronicity Study Evaluating Yutiqhttps://modernod.com/news/alimera-completes-recruitment-for-the-synchronicity-study-evaluating-yutiq/2482044/Alimera Sciences announced that it has completed enrollment for the company’s Synchronicity study, a prospective, open-label clinical study evaluating the safety and efficacy of Yutiq (fluocinolone acetonide intravitreal implant 0.18mg) in the treatment of chronic noninfectious uveitis